Skip to main content
. 2019 Oct 22;68(12):1949–1958. doi: 10.1007/s00262-019-02418-5

Fig. 4.

Fig. 4

Rechallenge tumor development in CT26-bearing mice treated with DaRT vs. inert seed combined with immunomodulators. Mice were inoculated with 5 × 105 CT26 tumor cells and then treated with DaRT or inert seeds combined with immunomodulators CpG, CP, and sildenafil. Cured mice or tumor-resected mice were rechallenged ~ 4 months after DaRT with 5 × 106 CT26 tumor cells